Stocks · Health care · Biological Products, (No Diagnostic Substances)

Ginkgo Bioworks Holdings, Inc.

DNA Clue Score24
United States Fiscal year ends December CIK 0001830214 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Jason R Kelly
8 Apr 2026
See remarks
Sold after exercise
97,015
$6.93
$672.31K
Barry Canton
8 Apr 2026
10% owner
Sold after exercise
13,155
$6.93
$91.16K
Reshma P. Shetty
8 Apr 2026
See remarks
Sold after exercise indirect
13,155
$6.93
$91.16K
Showing 250 of 779 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 443
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 242
Sales straight out of an exercise 7
Sales at will 526
Transactions with no price 1
Shares from compensation/vesting 451,958,822
Sales filed before the plan box existed 443
History held since 20 Sep 2021